PRESS RELEASE published on 04/06/2023 at 18:00, 1 year 7 months ago Lepermislibre: 2022 full-year results and Q1 2023 revenue
PRESS RELEASE published on 04/06/2023 at 14:38, 1 year 7 months ago Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
PRESS RELEASE published on 03/13/2023 at 18:18, 1 year 8 months ago Lepermislibre: 2023 Financial Calendar
PRESS RELEASE published on 03/13/2023 at 18:18, 1 year 8 months ago Lepermislibre: Calendrier de communication financière 2023
PRESS RELEASE published on 03/07/2023 at 17:56, 1 year 8 months ago Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
PRESS RELEASE published on 02/08/2023 at 19:07, 1 year 9 months ago Lepermislibre: Lepermislibre announces the success of its IPO on the Euronext Growth® market in Paris
PRESS RELEASE published on 02/08/2023 at 19:07, 1 year 9 months ago Lepermislibre: Lepermislibre annonce le succès de son introduction en bourse sur Euronext Growth® Paris
PRESS RELEASE published on 01/25/2023 at 07:30, 1 year 9 months ago Lepermislibre: Lepermislibre annonce le lancement de son introduction en bourse sur le marché Euronext Growth® Paris
PRESS RELEASE published on 01/25/2023 at 07:30, 1 year 9 months ago Lepermislibre: Lepermislibre announces the launch of its IPO on the Euronext Growth® market in Paris
PRESS RELEASE published on 01/16/2023 at 07:30, 1 year 10 months ago Lepermislibre:Lepermislibre annonce l’approbation de son Document d’enregistrement par l’Autorité des Marchés Financiers dans le cadre de son projet d’introduction en bourse sur Euronext Growth® Paris
Published on 11/21/2024 at 13:00, 17 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 17 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 17 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 17 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 17 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 42 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 2 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 47 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 19 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 19 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 19 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 9 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 57 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
